Neutralizing activities of human immunoglobulin derived from donors in Japan against mosquitoborne flaviviruses, Japanese encephalitis virus, West Nile virus, and dengue virus

Biologics: Targets and Therapy

Volumn 10, Issue , 2016, Pages 99-102

  Yunoki, Mikihiro ^a,b,c   Kurosu, Takeshi ^b   Koketsu, Ritsuko Kubota ^b,d   Takahashi, Kazuo ^e   Okuno, Yoshinobu ^d   Ikuta, Kazuyoshi ^b,d  

^a Telecommunications Advancement   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c RAKUNO GAKUEN UNIVERSITY   (Japan)

^d Osaka University   (Japan)

^e OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Dengue virus; Intravenous immunoglobulin; Japanese encephalitis virus; Neutralization; West Nile virus

Indexed keywords

IMMUNOGLOBULIN; VIRUS ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DENGUE VIRUS; JAPAN; JAPANESE ENCEPHALITIS VIRUS; NONHUMAN; VIRUS ATTACHMENT; VIRUS NEUTRALIZATION; VIRUS REPLICATION; WEST NILE VIRUS;

EID: 84983353595     PISSN: 11775475     EISSN: 11775491     Source Type: Journal    
DOI: 10.2147/BTT.S105650     Document Type: Article

References (11)

1. King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ. Ninth Report of the International Committee on Taxonomy of Viruses. London: Elsevier Academic Press; 2012.
2. Campbell GL, Hills SL, Fischer M, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ. 2011; 89: 766–774.
3. Fischer M, Lindsey N, Staples JE, Hills S; Center for Disease Control and Prevention (CDC). Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010; 59 (RR-1): 1–27.
4. Infectious disease surveillance in Japan 2013 [in Japanese]. Available from: http: //www.nih.go.jp/niid/ja/survei/2085-idwr/ydata/5194-reportja2013-20.html. Accessed May 31, 2016.
5. Arima Y, Matsui T, Shimada T, et al. Ongoing local transmission of dengue in Japan, August to September 2014. Western Pac Surveill Response J. 2014; 5 (4): 27–29.
6. Planitzer CB, Modrof J, Yu MW, Kreil TR. West Nile virus infection in plasma of blood and plasma donors, United States. Emerg Infect Dis. 2009; 15 (10): 1668–1670.
7. Jirakanjanakit N, Sanohsomneing T, Yoksan S, Bhamarapravati N. The micro-focus reduction neutralization test for determining dengue and Japanese encephalitis neutralizing antibodies in volunteers vaccinated against dengue. Trans R Soc Trop Med Hyg. 1997; 91 (5): 614–617.
8. Lim CK, Takasaki T, Kotaki A, Kurane I. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine. Virology. 2008; 374: 60–70.
9. Masrinoul P, Omokoko MD, Pambudi S, Ikuta K, Kurosu T. Serotypespecific anti-dengue virus NS1 mouse antibodies cross-react with prM and are potentially involved in virus production. Viral Immunol. 2013; 26 (4): 250–258.
10. Takasaki T, Yabe S, Nerome R, Ito M, Yamada K, Kurane I. Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice. Vaccine. 2003; 21: 4514–4518.
11. Kanesa-Thasan N, Putnak JR, Mangiafico JA, Saluzzo JE, Ludwig GV. Short report: Absence of protective neutralizing antibodies to West Nile Virus in subjects following vaccination with Japanese encephalitis or dengue vaccines. Am J Trop Med Hyg. 2002; 66 (2): 115–116.